CH EPL (R5)
1.0.0-ballot - ballot Switzerland flag

This page is part of the CH EPL (R5) (v1.0.0-ballot: DSTU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions

Example RegulatedAuthorization: 5204201

Generated Narrative: RegulatedAuthorization MA-5204201

identifier: http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber/5204201

subject: MedicinalProductDefinition: extension = Tablet and solvent for rectal suspension,Distale Form der Colitis ulcerosa bei ungenügendem Ansprechen auf oder Kontraindikation für Mesalazin.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7601001346451-5204201; domain = Human; combinedPharmaceuticalDoseForm = Tablet and solvent for rectal suspension; indication = Leichte bis mittelschwere Colitis ulcerosa des Rectums sowie des Colon sigmoideum.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = budesonide,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 1993-06-18

holder: Organization Tillotts Pharma AG

regulator: Organization SMC

Generated Narrative: Organization #holder-Tillotts-Pharma-AG

identifier: LOC Identifier/100005174, GLN Identifier/7601001346451

name: Tillotts Pharma AG

Generated Narrative: Organization #regulator-SMC

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: SMC